RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..2 of 2 - per page
Order by
Rx and /or OTC dermatology products
We are focused on licensing or acquiring new, late-stage technologies or existing prescription or OTC dermatology products More
New Chemical Entities and innovative therapeutic targets
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Fungal Infection and Candidiasis Therapy Area Pipeline Report
Nov 2010 - 920 pages - $1,495
Medicis Pharmaceutical Corporation: Premium Company Profile
Dec 2007 - 49 pages - $495
Company Financials: Medicis Pharmaceutical Corporation
Jan 2010 - $75
The World Dermatological Market Outlook 2010-2024
Nov 2009 - 142 pages - $2,350
The Dermatology Market Outlook to 2016
Jul 2011 - 96 pages - $3,835
Fungal Infections - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Dermatological Drugs: World Market 2011-2026
Nov 2010 - 189 pages - $2,350
Diabetic Foot Infection (DFI) - Pipeline Review, Q1 2011
Jan 2011 - 20 pages - $500
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Apr 2008 - 52 pages - $1,995
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Dermatological del
Fungal infection del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription
Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us